These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19903847)

  • 1. Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor.
    Kuo PC; Tsao YP; Chang HW; Chen PH; Huang CW; Lin ST; Weng YT; Tsai TC; Shieh SY; Chen SL
    Cancer Res; 2009 Dec; 69(23):8877-85. PubMed ID: 19903847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of estrogen receptor transcriptional activity by breast cancer amplified sequence 2.
    Qi C; Zhu YT; Chang J; Yeldandi AV; Rao MS; Zhu YJ
    Biochem Biophys Res Commun; 2005 Mar; 328(2):393-8. PubMed ID: 15694360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer.
    Yang H; Wen YY; Zhao R; Lin YL; Fournier K; Yang HY; Qiu Y; Diaz J; Laronga C; Lee MH
    Cancer Res; 2006 Mar; 66(6):3096-105. PubMed ID: 16540659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.
    Yan W; Chen X
    Cancer Res; 2007 Oct; 67(19):9117-24. PubMed ID: 17909016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis.
    Park K; Kim K; Rho SB; Choi K; Kim D; Oh SH; Park J; Lee SH; Lee JH
    Cancer Res; 2005 Feb; 65(3):749-57. PubMed ID: 15705871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The autocrine human secreted PDZ domain-containing protein 2 (sPDZD2) induces senescence or quiescence of prostate, breast and liver cancer cells via transcriptional activation of p53.
    Tam CW; Liu VW; Leung WY; Yao KM; Shiu SY
    Cancer Lett; 2008 Nov; 271(1):64-80. PubMed ID: 18639375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis.
    Li N; Zheng Y; Chen W; Wang C; Liu X; He W; Xu H; Cao X
    Cancer Res; 2007 Dec; 67(23):11176-85. PubMed ID: 18056442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
    Mannefeld M; Klassen E; Gaubatz S
    Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skp2 suppresses p53-dependent apoptosis by inhibiting p300.
    Kitagawa M; Lee SH; McCormick F
    Mol Cell; 2008 Feb; 29(2):217-31. PubMed ID: 18243116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.
    Singh K; Mogare D; Giridharagopalan RO; Gogiraju R; Pande G; Chattopadhyay S
    PLoS One; 2007 Aug; 2(7):e660. PubMed ID: 17668048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel small molecule induces p53-dependent apoptosis in human colon cancer cells.
    Park SE; Min YK; Ha JD; Kim BT; Lee WG
    Biochem Biophys Res Commun; 2007 Jul; 358(3):842-7. PubMed ID: 17509529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of DNA binding and transcriptional regulatory function of an endogenous mutant p53 in MDA-468 human breast cancer cells.
    Prasad KA; Church JG
    Biochem Biophys Res Commun; 1997 Mar; 232(1):14-9. PubMed ID: 9125118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel domain of BRCA1 interacts with p53 in breast cancer cells.
    Buck M
    Cancer Lett; 2008 Sep; 268(1):137-45. PubMed ID: 18501503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
    Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
    Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of ANKRD11 as a p53 coactivator.
    Neilsen PM; Cheney KM; Li CW; Chen JD; Cawrse JE; Schulz RB; Powell JA; Kumar R; Callen DF
    J Cell Sci; 2008 Nov; 121(Pt 21):3541-52. PubMed ID: 18840648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Spot 14 protein is a p53-dependent transcriptional coactivator via the recruitment of thyroid receptor and Zac1.
    Chou WY; Ho CL; Tseng ML; Liu ST; Yen LC; Huang SM
    Int J Biochem Cell Biol; 2008; 40(9):1826-34. PubMed ID: 18299245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microtubule-associated protein 1B light chain (MAP1B-LC1) negatively regulates the activity of tumor suppressor p53 in neuroblastoma cells.
    Lee SY; Kim JW; Jeong MH; An JH; Jang SM; Song KH; Choi KH
    FEBS Lett; 2008 Aug; 582(19):2826-32. PubMed ID: 18656471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification.
    Zou B; Chim CS; Pang R; Zeng H; Dai Y; Zhang R; Lam CS; Tan VP; Hung IF; Lan HY; Wong BC
    Mol Carcinog; 2012 May; 51(5):422-32. PubMed ID: 21678496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
    Montano X
    Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.